Spots Global Cancer Trial Database for Gustave Roussy Cancer Profiling

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Gustave Roussy Cancer Profiling

Official Title: Gustave Roussy Cancer Profiling

Study ID: NCT04932525

Conditions

Solid Tumor, Unspecified, Adult

Interventions

Biopsy

Study Description

Brief Summary: The objective of STING study is to perform high throughput molecular analysis (next generation sequencing +/- immunological profiling) to estimate the proportion of patients with cancer presenting at least one targetable genomic alteration.

Detailed Description: STING is a biology driven, multicenter study designed to identify actionable molecular alterations in cancer patients and to explore mechanisms of sensitivity and resistance to anti-cancer treatment * In this trial, high throughput analysis will be carried out using next generation sequencing, and immunological profiling * Patients included in the STING study and for whom a targetable genomic alteration had been identified might be subsequently included in a clinical trial running at Gustave Roussy or another participating center.